# K091593: Angio Jet Ultra DVX and Xpeedior Thrombectomy Sets

- Pathway: 510(k) (Special)
- Applicant: Possis Medical, Inc.
- Decided: Jun 22, 2009 after 20 days
- Product code: QEZ (Aspiration Thrombectomy Catheter)
- Device class: 2
- Regulation: 21 CFR 870.5150
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K901627 (1990). 18 ancestors in all.
31 later devices descend from it; 3 cite it directly.
1 of 50 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071342: Angiojet Ultra Xpeedior Thrombectomy Set, Model 105040, 105042, 106552, 105043, 105041, 106553, 105039, Possis Medical, Inc. (2007) Summary page 1.
- K090253: Angiojet Ultra DVX Thrombectomy Set, Model 106552-001, Angiojet Ultra Xpeedior Thrombectomy Set, Model 105040-001, Possis Medical, Inc. (2009) Summary page 1.
- K072269: Angiojet Ultra DVX Thrombectomy Set, Model: 106552, Possis Medical, Inc. (2007) Summary page 1.

## Most influential descendants
- K101406: Angiojet Solent Proxi Thrombectomy Set Model 109676-001 (2010), 30 descendants of its own
- K111182: Angiojet Solent Omni Thrombectomy Set (2011), 28 descendants of its own
- K151313: ZelanteDVT Thrombectomy Set (2015), 26 descendants of its own
- K193462: ClotTriever Thrombectomy System (2020), 21 descendants of its own
- K210190: ClotTriever Thrombectomy System (2021), 20 descendants of its own

## Indications for use
The AngioJet Ultra DVX and Xpeedior Thrombectomy Sets are intended for use with the Angiojet Ultra Console to break apart and remove thrombus from: upper and lower extremity peripheral arteries > 3.0mm in diameter, upper extremity peripheral veins > 3.0mm in diameter, ileofemoral and lower extremity veins > 3.0mm in diameter, A-V access conduits > 3.0mm in diameter and for use with the Angiojet Ultra Power Pulse Kit for the control and selective infusion of physician specified fluids, including thrombolytic agents, into the peripheral vascular system.

Source page: https://510kreport.com/device/K091593
Methodology: https://510kreport.com/methodology